Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PADI4 facilitates stem-like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma. | Clin Transl Med | 2025 | 40078091 | PubTator, text mining | PubMed |
| Ubiquitin specific protease 7 is a potential therapeutic target for gastric cancer. | Front Oncol | 2025 | 40061891 | PubTator, text mining | PubMed |
| The potential value of microRNA-409-5p-mediated negative regulation of USP7 in the diagnosis and treatment of acute myocardial infarction. | BMC Cardiovasc Disord | 2025 | 40057674 | PubTator, text mining | PubMed |
| ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment. | Oncogene | 2025 | 40057605 | PubTator, text mining | PubMed |
| Profiling gene alterations in striatonigral neurons associated with incubation of methamphetamine craving by cholera toxin subunit B-based fluorescence-activated cell sorting. | Front Cell Neurosci | 2025 | 40012565 | PubTator, text mining | PubMed |
| Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways. | Pharmaceuticals (Basel) | 2025 | 40006058 | PubTator, text mining | PubMed |
| Sertraline and Astemizole Enhance the Deubiquitinase Activity of USP7 by Binding to Its Switching Loop Region. | J Med Chem | 2025 | 39999290 | PubTator, text mining | PubMed |
| Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression. | Cancer Cell Int | 2025 | 39985032 | PubTator, text mining | PubMed |
| Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7. | Structure | 2025 | 39983720 | PubTator, text mining | PubMed |
| Chemical approaches to explore ubiquitin-like proteins. | RSC Chem Biol | 2025 | 39950163 | PubTator, text mining | PubMed |
| Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis. | Oncogene | 2025 | 39939725 | PubTator, text mining | PubMed |
| The FBXW7-RPAP2 Axis Controls the Growth of Hepatocellular Carcinoma Cells and Determines the Fate of Liver Cell Differentiation. | Adv Sci (Weinh) | 2025 | 39932049 | PubTator, text mining | PubMed |
| Identification and optimization of a small molecule inhibitor of the ovarian tumor protease of the Crimean-Congo hemorrhagic fever virus. | Bioorg Med Chem | 2025 | 39923558 | PubTator, text mining | PubMed |
| USP7 deficiency promotes diabetic wound healing by repressing GATA3-mediated pro-inflammatory macrophage polarization. | Mol Cell Endocrinol | 2025 | 39921129 | PubTator, text mining | PubMed |
| Hao-Fountain syndrome protein USP7 controls neuronal differentiation via BCOR-ncPRC1.1. | Genes Dev | 2025 | 39919828 | PubTator, text mining | PubMed |
| Deubiquitinase processing of a non-natural linkage of ubiquitinated-PTEN. | Bioorg Chem | 2025 | 39919325 | PubTator, text mining | PubMed |
| Recent advances in small molecule inhibitors of deubiquitinating enzymes. | Eur J Med Chem | 2025 | 39908798 | PubTator, text mining | PubMed |
| Redox-Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3-Mediated NRF2 Deubiquitination. | Adv Sci (Weinh) | 2025 | 39887666 | PubTator, text mining | PubMed |
| Usp7 contributes to the tail regeneration of planarians via Islet/Wnt1 axis. | J Transl Med | 2025 | 39885534 | PubTator, text mining | PubMed |
| The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer. | Biochim Biophys Acta Mol Cell Res | 2025 | 39880128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=14